RxDoctor Payments Data

Li Wei Chang, MD

MOHS-Micrographic Surgery · Chillicothe, OHNPI 1215468178

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 48.1% of the total. Reporting peaked in 2019 at $364 and has fallen 94.1% since, to $22 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in OH, where the typical reported total is $1,196.

$1,057in general payments, 2019–2025

Across 42 payments — averaging $25.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$509
  • Stemline Therapeutics Inc.$103
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$70
  • Boehringer Ingelheim$51
  • Incyte Corporation$50
  • UCB, Inc.$48
  • plus $227 from 8 others

What the payments were for

  • Food & beverage$1,04198%
  • Education$162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,057 in reported general payments places this provider in the 40th percentile of 35 mohs-micrographic surgery providers in Ohio.

See all mohs-micrographic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$396,020
Medicare patients
478
Services billed
1,496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate36$345
Doxycycline Hyclate53$254

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Chillicothe

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →